839
Participants
Start Date
April 13, 2021
Primary Completion Date
September 22, 2021
Study Completion Date
March 3, 2022
aQII-1
Biological/Vaccine: Investigational aQII-1 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-3 Investigational
Biological/Vaccine: Investigational aQII-3 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-6 Investigational
Biological/Vaccine: Investigational aQII-6 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-7 Investigational
Biological/Vaccine: Investigational aQII-7 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-9 Investigational
Biological/Vaccine: Investigational aQII-9 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-10 Investigational
Biological/Vaccine: Investigational aQII-10 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
aQII-11 Investigational
Biological/Vaccine: Investigational aQII-11 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
Licensed QII Active Comparator
Biological/Vaccine: Licensed QII Licensed Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.
60805 - Manila Doctors' Hospital, Ermita
60803 - Philippine General Hospital, Manila
55406 - Optimal Clinical Trials, Auckland
71006 - Mzansi Ethical Research Centre (MERC), Mpumalanga
60804 - Quirino Memorial Medical Center, Quezon City
71001 - Wits Clinical Researc - Chris Hani Baragwanath Academic Hospital, Soweto
3610- Emeritis Research, Botany
03608 - Australian Clinical Research Network - ACRN [NSW], Maroubra
3609 - Northern Beaches Clinical Research [NSW], Brookvale
71003- Newtown Clinical Research, Newtown
03605 - PCRN_Paratus Clinical Research (Central Coast), Blacktown
03602 - PCRN_Paratus Clinical Research,(Western Sydney) [NSW], Kanwal
03607 - PCRN_Paratus Clinical Research, Bruce
3611 - The University of Melbourne Peter Doherty Institute for Infection and Immunity, Melbourne
55405 - PCRN_Lakeland Clinical Trials, Rotorua
55403-PCRN_Lakeland Clinical Trials Waikato, Hamilton
03601 - AusTrials Taringa [QLD], Taringa
60801 - De La Salle Medical and Health Sciences Institute, Dasmariñas
03606 - AusTrials Tarragindi (Aus Trial Wellers Hill)[QLD], Tarragindi
03604 - University of the Sunshine Coast Clinical Trials Centre, Morayfield
03603 - University of the Sunshine Coast, Sippy Downs
60802 - West Visayas University Medical Center, Jaro
71004 - Tread Research -- Tygerberg Hospital, Cape Town
71005 South Africa Haylene71005 - Tiervlei Trial Centre -- Karl Bremer Hospital, Bellville
71009 - Be Part Yoluntu Centre, Paarl
55404- PCRN_Southern Clinical Trials Christchurch, Christchurch
71002 - JOSHA Research, Bloemfontein
71011 - Farmovs, Bloemfontein
55402- PCRN_Southern Clinical Trials Waitemata, Birkenhead
55401- PCRN_Southern Clinical Trials Totara, New Lynn
Seqirus
INDUSTRY